A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
Clinical trial NCT01712217 · COMPLETED
Trial details
- NCT number
- NCT01712217
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-12-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.